These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7674467)

  • 1. Protamine use during peripheral vascular surgery: a prospective randomized trial.
    Dorman BH; Elliott BM; Spinale FG; Bailey MK; Walton JS; Robison JG; Brothers TE; Cook MH
    J Vasc Surg; 1995 Sep; 22(3):248-55; discussion 256. PubMed ID: 7674467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel protamine variant reversal of heparin anticoagulation in human blood in vitro.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Stoneham MD; Doyle AR; Zelenock GB; Jacobs LA; Shanley CJ; TenCate VM; Stanley JC
    J Vasc Surg; 1997 Dec; 26(6):1043-8. PubMed ID: 9423721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.
    Radulovic V; Laffin A; Hansson KM; Backlund E; Baghaei F; Jeppsson A
    PLoS One; 2015; 10(7):e0130271. PubMed ID: 26134993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of differing rates of protamine reversal of heparin anticoagulation.
    Wakefield TW; Hantler CB; Wrobleski SK; Crider BA; Stanley JC
    Surgery; 1996 Feb; 119(2):123-8. PubMed ID: 8571194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the activated coagulation time and heparin dose-response curve for the determination of protamine dosage in vascular surgery.
    Szalados JE; Ouriel K; Shapiro JR
    J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):515-8. PubMed ID: 7803739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
    Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study.
    Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine pretreatment attenuation of hemodynamic and hematologic effects of heparin-protamine interaction. A prospective randomized study in human beings undergoing aortic reconstructive surgery.
    Wakefield TW; Hantler CB; Lindblad B; Whitehouse WM; Stanley JC
    J Vasc Surg; 1986 Jun; 3(6):885-9. PubMed ID: 3712636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.
    Jobes DR; Aitken GL; Shaffer GW
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery.
    Kuitunen AH; Salmenperä MT; Heinonen J; Rasi VP; Myllylä G
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):221-6. PubMed ID: 1863741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: A randomized controlled trial.
    Ghannam M; Chugh A; Dillon P; Alyesh D; Kossidas K; Sharma S; Coatney J; Atreya A; Yokokawa M; Saeed M; Cunnane R; Ghanbari H; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2018 Nov; 15(11):1642-1647. PubMed ID: 30661768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two doses of heparin on outcome in off-pump coronary artery bypass surgery patients: A prospective randomized control study.
    Chakravarthy M; Prabhakumar D; Thimmannagowda P; Krishnamoorthy J; George A; Jawali V
    Ann Card Anaesth; 2017; 20(1):8-13. PubMed ID: 28074788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculation Algorithm Reduces Protamine Doses Without Increasing Blood Loss or the Transfusion Rate in Cardiac Surgery: Results of a Randomized Controlled Trial.
    Kjellberg G; Holm M; Fux T; Lindvall G; van der Linden J
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):985-992. PubMed ID: 30206011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
    Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
    Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.